Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06601322 · ClinicalTrials.gov registry record · NA
Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right)
A NA study of RV - Right Ventricular Abnormality and Left Branch Bundle Block, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06601322: Recruiting NA study of RV - Right Ventricular Abnormality and Left Branch Bundle Block, sponsored by Virginia Commonwealth University.
NCT06601322 is a NA study of RV - Right Ventricular Abnormality and Left Branch Bundle Block that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06601322, a NA study of RV - Right Ventricular Abnormality and Left Branch Bundle Block, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective single center clinical trial is to evaluate the safety and feasibility of performing simultaneous exercise stress cardiac magnetic resonance (CPET-CMR) and cardiopulmonary exercise testing in patients with pre-existing left bundle branch area pacemakers (LBBAP) programmed to an atrial sensing mode. Measurements of right ventricular, left ventricular function, and exercise capacity will be obtained at various LBBAP programming parameters at rest and during low intensity exercise. The main aims of the study are: * Demonstrate the safety and feasibility of performing CPET-CMR in patients with pre-existing LBBAP programmed to P-synchronous ventricular pacing mode. * Generate preliminary data evaluating differences in RV function, LV function, and exercise capacity during various pacemaker programming settings.
Primary Outcome
Incidence of pacemaker atrial (P Wave) over sensing as derived from continuous pacemaker telemetry at optimal programmed atrial sensitivity.
Conditions Studied
Interventions
- OTHER Pacemaker Interrogation and Electrocardiogram (ECG):
- OTHER Cardiopulmonary Exercise Test (CPET) and Exercise Stress Cardiac Magnetic Resonance (ExeCMR
- OTHER Continuous pacemaker telemetry (CPT)
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-08-23 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT06601322 shows while recruiting
NCT06601322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with RV - Right Ventricular Abnormality appearing as the primary indexed condition, and to 3 interventions - of which Pacemaker Interrogation and Electrocardiogram (ECG): is the first listed.
NCT06601322 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06601322 about?
NCT06601322 is a clinical study titled "Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right)". The goal of this prospective single center clinical trial is to evaluate the safety and feasibility of performing simultaneous exercise stress cardiac magnetic resonance (CPET-CMR) and cardiopulmonary exercise testing in patients with pre-existing left bundle branch area pacemakers (LBBAP) programme...
What is the current status of trial NCT06601322?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-08-23. Estimated completion is 2026-03.
What conditions does trial NCT06601322 study?
This clinical trial studies the following conditions: RV - Right Ventricular Abnormality, Left Branch Bundle Block.
What interventions are being tested in trial NCT06601322?
The interventions under investigation include: Pacemaker Interrogation and Electrocardiogram (ECG): (OTHER), Cardiopulmonary Exercise Test (CPET) and Exercise Stress Cardiac Magnetic Resonance (ExeCMR (OTHER), Continuous pacemaker telemetry (CPT) (OTHER).
Who is sponsoring clinical trial NCT06601322?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06601322 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for RV - Right Ventricular Abnormality
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06601322's enrollment target sits among peer trials
20 1769th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI